Your browser doesn't support javascript.
loading
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial.
Lancet Oncol ; 13(7): 696-706, 2012 Jul.
Article en En | MEDLINE | ID: mdl-22652183

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Terapia Recuperativa / Isoquinolinas / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2012 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Terapia Recuperativa / Isoquinolinas / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2012 Tipo del documento: Article